CIK: 0001306923 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value ($000): $886,726 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 4,423,369 | $120,006 | 13.5% | $17.79 | +57.3% | COM PAR $.01 | 457669307 |
| FOLD | AMICUS THERAPEUTICS INC | 9,344,102 | $110,074 | 12.4% | $9.63 | +32.9% | COM | 03152W109 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,134,569 | $99,093 | 11.2% | $83.16 | +7.7% | COM | 09061G101 |
| BIIB | BIOGEN INC | 289,958 | $62,524 | 7.1% | $264.98 | -11.6% | COM | 09062X103 |
| UTHR | UNITED THERAPEUTICS CORP | 267,759 | $61,510 | 6.9% | $89.23 | +152.9% | COM | 91307C102 |
| STAA | STAAR SURGICAL CO | 1,379,590 | $52,811 | 6.0% | $24.23 | +34.2% | COM PAR $0.01 | 852312305 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,414,943 | $44,652 | 5.0% | $28.41 | -12.8% | COM | 004225108 |
| PRTA | PROTHENA CORP PLC | 1,663,448 | $41,204 | 4.6% | $21.46 | +38.7% | SHS | G72800108 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 2,112,811 | $31,312 | 3.5% | $5.23 | +122.4% | COM | 462260100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 182,766 | $27,314 | 3.1% | $169.79 | -1.8% | COM | 02043Q107 |
| SRPT | SAREPTA THERAPEUTICS INC | 201,265 | $26,056 | 2.9% | $111.32 | +10.0% | COM | 803607100 |
| — | REVANCE THERAPEUTICS INC | 5,248,004 | $25,820 | 2.9% | $21.40 | — | COM | 761330109 |
| — | SAGE THERAPEUTICS INC | 1,005,776 | $18,848 | 2.1% | $42.50 | — | COM | 78667J108 |
| ANAB | ANAPTYSBIO INC | 799,906 | $18,014 | 2.0% | $19.13 | +23.8% | COM | 032724106 |
| EHTH | EHEALTH INC | 2,715,681 | $16,376 | 1.8% | $38.13 | -82.6% | COM | 28238P109 |
| ALGN | ALIGN TECHNOLOGY INC | 49,105 | $16,103 | 1.8% | $149.18 | +96.7% | COM | 016255101 |
| ALKS | ALKERMES PLC | 495,592 | $13,416 | 1.5% | $22.36 | +27.0% | SHS | G01767105 |
| — | ACELYRIN INC | 1,715,180 | $11,577 | 1.3% | $6.75 | — | COM | 00445A100 |
| — | NEVRO CORP | 750,371 | $10,835 | 1.2% | $21.87 | — | COM | 64157F103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 405,193 | $9,644 | 1.1% | $16.84 | +32.5% | COM | 87164F105 |
| NVCR | NOVOCURE LTD | 561,908 | $8,783 | 1.0% | $58.84 | -75.0% | ORD SHS | G6674U108 |
| CYTK | CYTOKINETICS INC | 111,717 | $7,832 | 0.9% | $6.71 | +1052.1% | COM NEW | 23282W605 |
| — | KARYOPHARM THERAPEUTICS INC | 5,102,193 | $7,704 | 0.9% | $16.36 | — | COM | 48576U106 |
| — | VERVE THERAPEUTICS INC | 575,817 | $7,647 | 0.9% | $13.94 | — | COM | 92539P101 |
| GOSS | GOSSAMER BIO INC | 6,391,775 | $7,542 | 0.9% | $1.58 | -30.3% | COM | 38341P102 |
| — | ELEVATION ONCOLOGY INC | 1,346,666 | $6,908 | 0.8% | $5.13 | — | COM | 28623U101 |
| — | BLUEBIRD BIO INC | 4,560,171 | $5,837 | 0.7% | $1.35 | — | COM | 09609G100 |
| RLMD | RELMADA THERAPEUTICS INC | 732,400 | $3,406 | 0.4% | $3.27 | +47.3% | COM | 75955J402 |
| NUVB | NUVATION BIO INC | 772,652 | $2,812 | 0.3% | $1.92 | 0.0% | COM | 67080N101 |
| TSHA | TAYSHA GENE THERAPIES INC | 811,268 | $2,328 | 0.3% | $2.02 | +2.9% | COM SHS | 877619106 |
| STOK | STOKE THERAPEUTICS INC | 125,861 | $1,699 | 0.2% | $6.06 | 0.0% | COM | 86150R107 |
| MIRM | MIRUM PHARMACEUTICALS INC | 64,700 | $1,625 | 0.2% | $15.56 | +76.7% | COM | 604749101 |
| HUM | HUMANA INC | 3,985 | $1,382 | 0.2% | $369.63 | 0.0% | COM | 444859102 |
| VYNE | VYNE THERAPEUTICS INC | 445,434 | $1,367 | 0.2% | $3.12 | -30.9% | COM | 92941V308 |
| TVTX | TRAVERE THERAPEUTICS INC | 110,719 | $854 | 0.1% | $23.56 | -64.2% | COM | 89422G107 |
| ALDX | ALDEYRA THERAPEUTICS INC | 225,465 | $737 | 0.1% | $5.95 | -44.7% | COM | 01438T106 |
| ACRS | ACLARIS THERAPEUTICS INC | 569,832 | $707 | 0.1% | $1.19 | 0.0% | COM | 00461U105 |
| URGN | UROGEN PHARMA LTD | 24,500 | $368 | 0.0% | $27.01 | -39.5% | COM | M96088105 |